Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies

被引:142
作者
Ellinger-Ziegelbauer, Heidrun [1 ]
Grnuender, Hans [2 ]
Brandenburg, Arnd [2 ]
Ahr, Hans Juergen [1 ]
机构
[1] Bayer HealthCare, Dept Mol & Special Toxicol, D-42096 Wuppertal, Germany
[2] Genedata AG, CH-4016 Basel, Switzerland
关键词
toxicogenomics; genotoxic carcinogens; non-genotoxic carcinogens; biomarkers; classification;
D O I
10.1016/j.mrfmmm.2007.06.010
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The carcinogenic potential of chemicals is currently evaluated with rodent life-time bioassays, which are time consuming, and expensive with respect to cost, number of animals and amount of compound required. Since the results of these 2-year bioassays are not known until quite late during development of new chemical entities, and since the short-term test battery to test for genotoxicity, a characteristic of genotoxic carcinogens, is hampered by low specificity, the identification of early biomarkers for carcinogenicity would be a big step forward. Using gene expression profiles from the livers of rats treated up to 14 days with genotoxic and non-genotoxic carcinogens we previously identified characteristic gene expression profiles for these two groups of carcinogens. We have now added expression profiles from further hepatocarcinogens and from non-carcinogens the latter serving as control profiles. We used these profiles to extract biomarkers discriminating genotoxic from non-genotoxic carcinogens and to calculate classifiers based on the support vector machine (SVM) algorithm. These classifiers then predicted a set of independent validation compound profiles with up to 88% accuracy, depending on the marker gene set. We would like to present this study as proof of the concept that a classification of carcinogens based on short-term studies may be feasible. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:23 / 39
页数:17
相关论文
共 76 条
[21]  
FLAKS B, 1985, ACTA PATH MICRO IM A, V93, P367
[22]   Supplement to the Carcinogenic Potency Database (CPDB): Results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998 [J].
Gold, LS ;
Manley, NB ;
Slone, TH ;
Rohrbach, L ;
Garfinkel, GB .
TOXICOLOGICAL SCIENCES, 2005, 85 (02) :747-808
[23]  
Hamadeh HK, 2002, TOXICOL SCI, V67, P219, DOI 10.1093/toxsci/67.2.219
[24]  
Hara Y, 1983, Nihon Yakurigaku Zasshi, V82, P103
[25]   CHARACTERISTICS OF THE HEPATOCARCINOGENESIS CAUSED BY DEHYDROEPIANDROSTERONE, A PEROXISOME PROLIFERATOR, IN MALE F344 RATS [J].
HAYASHI, F ;
TAMURA, H ;
YAMADA, J ;
KASAI, H ;
SUGA, T .
CARCINOGENESIS, 1994, 15 (10) :2215-2219
[26]  
HECHT SS, 1980, CANCER RES, V40, P298
[27]   AN EVALUATION OF THE ESCHERICHIA-COLI K-12 UVRB/RECA DNA-REPAIR HOST-MEDIATED ASSAY .2. INVIVO RESULTS FOR 36 COMPOUNDS TESTED IN THE MOUSE [J].
HELLMER, L ;
BOLCSFOLDI, G .
MUTATION RESEARCH, 1992, 272 (02) :161-173
[28]   ANTIHYPERTENSIVE EFFECT OF COMBINED TREATMENT WITH ALPHA-ADRENERGIC AND BETA-ADRENERGIC BLOCKERS IN SPONTANEOUSLY HYPERTENSIVE RAT [J].
IGARASHI, T ;
NAKAJIMA, Y ;
OHTAKE, S .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1977, 41 (08) :903-911
[29]  
Ishii R, 1998, ARZNEIMITTEL-FORSCH, V48, P811
[30]  
JACKSON B, 1961, LAB INVEST, V10, P909